These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32133495)

  • 1. Locally acting transcription factors regulate p53-dependent cis-regulatory element activity.
    Catizone AN; Uzunbas GK; Celadova P; Kuang S; Bose D; Sammons MA
    Nucleic Acids Res; 2020 May; 48(8):4195-4213. PubMed ID: 32133495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genome-integrated massively parallel reporter assay reveals DNA sequence determinants of cis-regulatory activity in neural cells.
    Maricque BB; Dougherty JD; Cohen BA
    Nucleic Acids Res; 2017 Feb; 45(4):e16. PubMed ID: 28204611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial interactions of p53, activating protein-2, and YB-1 with a single enhancer element regulate gelatinase A expression in neoplastic cells.
    Mertens PR; Steinmann K; Alfonso-Jaume MA; En-Nia A; Sun Y; Lovett DH
    J Biol Chem; 2002 Jul; 277(28):24875-82. PubMed ID: 11973333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal and differential regulation of KAISO-controlled transcription by phosphorylated and acetylated p53 highlights a crucial regulatory role of apoptosis.
    Choi SH; Koh DI; Cho SY; Kim MK; Kim KS; Hur MW
    J Biol Chem; 2019 Aug; 294(35):12957-12974. PubMed ID: 31296660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic and genomic regulatory elements reveal aspects of
    King DM; Hong CKY; Shepherdson JL; Granas DM; Maricque BB; Cohen BA
    Elife; 2020 Feb; 9():. PubMed ID: 32043966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRE-transcription factor decoy oligonucleotide inhibition of MCF-7 breast cancer cells: cross-talk with p53 signaling pathway.
    Lee YN; Park YG; Choi YH; Cho YS; Cho-Chung YS
    Biochemistry; 2000 Apr; 39(16):4863-8. PubMed ID: 10769144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CerS6 Is a Novel Transcriptional Target of p53 Protein Activated by Non-genotoxic Stress.
    Fekry B; Jeffries KA; Esmaeilniakooshkghazi A; Ogretmen B; Krupenko SA; Krupenko NI
    J Biol Chem; 2016 Aug; 291(32):16586-96. PubMed ID: 27302066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of p53 as a transcription factor in the induction of apoptosis.
    Yonish-Rouach E; Choisy C; Deguin V; Breugnot C; May E
    Behring Inst Mitt; 1996 Oct; (97):60-71. PubMed ID: 8950467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin G is a transcriptional target of the p53 tumor suppressor protein.
    Okamoto K; Beach D
    EMBO J; 1994 Oct; 13(20):4816-22. PubMed ID: 7957050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p53 response element and transcriptional repression.
    Wang B; Xiao Z; Ko HL; Ren EC
    Cell Cycle; 2010 Mar; 9(5):870-9. PubMed ID: 20160511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activation of p53 by Pitx1.
    Liu DX; Lobie PE
    Cell Death Differ; 2007 Nov; 14(11):1893-907. PubMed ID: 17762884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo prediction of cis-regulatory elements and modules through integrative analysis of a large number of ChIP datasets.
    Niu M; Tabari ES; Su Z
    BMC Genomics; 2014 Dec; 15():1047. PubMed ID: 25442502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor.
    Renault VM; Thekkat PU; Hoang KL; White JL; Brady CA; Kenzelmann Broz D; Venturelli OS; Johnson TM; Oskoui PR; Xuan Z; Santo EE; Zhang MQ; Vogel H; Attardi LD; Brunet A
    Oncogene; 2011 Jul; 30(29):3207-21. PubMed ID: 21423206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Context dependent activity of p63-bound gene regulatory elements.
    McCann AA; Baniulyte G; Woodstock DL; Sammons MA
    bioRxiv; 2024 May; ():. PubMed ID: 38766006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cyclin-dependent kinase subunit 1 (Cks1) is regulated during the cell cycle by a CDE/CHR tandem element and is downregulated by p53 but not by p63 or p73.
    Rother K; Li YY; Tschöp K; Kirschner R; Müller GA; Mössner J; Engeland K
    Cell Cycle; 2007 Apr; 6(7):853-62. PubMed ID: 17377499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 Pre- and post-binding event theories revisited: stresses reveal specific and dynamic p53-binding patterns on the p21 gene promoter.
    Millau JF; Bastien N; Bouchard EF; Drouin R
    Cancer Res; 2009 Nov; 69(21):8463-71. PubMed ID: 19843844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression.
    Nip J; Hiebert SW
    Cell Biochem Biophys; 2000; 33(2):199-207. PubMed ID: 11325040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p202, an interferon-inducible modulator of transcription, inhibits transcriptional activation by the p53 tumor suppressor protein, and a segment from the p53-binding protein 1 that binds to p202 overcomes this inhibition.
    Datta B; Li B; Choubey D; Nallur G; Lengyel P
    J Biol Chem; 1996 Nov; 271(44):27544-55. PubMed ID: 8910340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cis-regulatory determinants of MyoD function.
    Soleimani VD; Nguyen D; Ramachandran P; Palidwor GA; Porter CJ; Yin H; Perkins TJ; Rudnicki MA
    Nucleic Acids Res; 2018 Aug; 46(14):7221-7235. PubMed ID: 30016497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.